Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Nelson Hayes

Showing results (61-70 of 161) with videos related to

Pageof 17
Sort By:
Scientific Reports|February 7, 2020
Publisher Correction: Regulation of the Hepatitis B virus replication and gene expression by the multi-functional protein TARDBPGrace Naswa Makokha, Hiromi Abe-Chayama, Sajeda Chowdhury, et al.
Journal of Hepatology|December 15, 2010
IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapyHiromi Abe, C Nelson Hayes, Hidenori Ochi, et al.
Plos One|June 18, 2015
Rapid, Sensitive, and Accurate Evaluation of Drug Resistant Mutant (NS5A-Y93H) Strain Frequency in Genotype 1b HCV by Invader AssaySatoshi Yoshimi, Hidenori Ochi, Eisuke Murakami, et al.
Antiviral Therapy|July 28, 2012
Identification of novel HCV deletion mutants in chronic hepatitis C patientsTomohiko Kohno, Masataka Tsuge, C Nelson Hayes, et al.
Journal of Gastroenterology|February 12, 2013
Serum HBV RNA and HBeAg are useful markers for the safe discontinuation of nucleotide analogue treatments in chronic hepatitis B patientsMasataka Tsuge, Eisuke Murakami, Michio Imamura, et al.
Scientific Reports|June 13, 2019
Regulation of the Hepatitis B virus replication and gene expression by the multi-functional protein TARDBPGrace Naswa Makokha, Hiromi Abe-Chayama, Sajeda Chowdhury, et al.
Hepatology (Baltimore, Md.)|February 15, 2012
Severe necroinflammatory reaction caused by natural killer cell-mediated Fas/Fas ligand interaction and dendritic cells in human hepatocyte chimeric mouseAkihito Okazaki, Nobuhiko Hiraga, Michio Imamura, et al.
The Journal of Infectious Diseases|June 2, 2011
IL28B but not ITPA polymorphism is predictive of response to pegylated interferon, ribavirin, and telaprevir triple therapy in patients with genotype 1 hepatitis CKazuaki Chayama, C Nelson Hayes, Hiromi Abe, et al.
Antiviral Therapy|November 13, 2015
Combination therapies with daclatasvir and asunaprevir on NS3-D168 mutated HCV in human hepatocyte chimeric miceHiromi Kan, Nobuhiko Hiraga, Michio Imamura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 7, 2015
Three patients treated with daclatasvir and asunaprevir for recurrent hepatitis C after liver transplantation: Case reportTomokazu Kawaoka, Michio Imamura, Kei Morio, et al.
Pageof 17

Showing results (61-70 of 161) with videos related to

Sort By:
Pageof 17
Scientific Reports|February 7, 2020
Publisher Correction: Regulation of the Hepatitis B virus replication and gene expression by the multi-functional protein TARDBPGrace Naswa Makokha, Hiromi Abe-Chayama, Sajeda Chowdhury, et al.
Journal of Hepatology|December 15, 2010
IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapyHiromi Abe, C Nelson Hayes, Hidenori Ochi, et al.
Plos One|June 18, 2015
Rapid, Sensitive, and Accurate Evaluation of Drug Resistant Mutant (NS5A-Y93H) Strain Frequency in Genotype 1b HCV by Invader AssaySatoshi Yoshimi, Hidenori Ochi, Eisuke Murakami, et al.
Antiviral Therapy|July 28, 2012
Identification of novel HCV deletion mutants in chronic hepatitis C patientsTomohiko Kohno, Masataka Tsuge, C Nelson Hayes, et al.
Journal of Gastroenterology|February 12, 2013
Serum HBV RNA and HBeAg are useful markers for the safe discontinuation of nucleotide analogue treatments in chronic hepatitis B patientsMasataka Tsuge, Eisuke Murakami, Michio Imamura, et al.
Scientific Reports|June 13, 2019
Regulation of the Hepatitis B virus replication and gene expression by the multi-functional protein TARDBPGrace Naswa Makokha, Hiromi Abe-Chayama, Sajeda Chowdhury, et al.
Hepatology (Baltimore, Md.)|February 15, 2012
Severe necroinflammatory reaction caused by natural killer cell-mediated Fas/Fas ligand interaction and dendritic cells in human hepatocyte chimeric mouseAkihito Okazaki, Nobuhiko Hiraga, Michio Imamura, et al.
The Journal of Infectious Diseases|June 2, 2011
IL28B but not ITPA polymorphism is predictive of response to pegylated interferon, ribavirin, and telaprevir triple therapy in patients with genotype 1 hepatitis CKazuaki Chayama, C Nelson Hayes, Hiromi Abe, et al.
Antiviral Therapy|November 13, 2015
Combination therapies with daclatasvir and asunaprevir on NS3-D168 mutated HCV in human hepatocyte chimeric miceHiromi Kan, Nobuhiko Hiraga, Michio Imamura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 7, 2015
Three patients treated with daclatasvir and asunaprevir for recurrent hepatitis C after liver transplantation: Case reportTomokazu Kawaoka, Michio Imamura, Kei Morio, et al.
Pageof 17